 | • レポートコード：QYR9N7800 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、がん治療薬のパーソナライズのグローバル市場について調査・分析したレポートで、種類別（免疫療法、ターゲット療法、化学療法、ホルモン療法、その他）、用途別（乳がん、血液がん、消化器がん、前立腺がん、皮膚がん、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・がん治療薬のパーソナライズの世界市場規模 ・主要企業別市場シェア ・がん治療薬のパーソナライズの世界市場規模：種類別（免疫療法、ターゲット療法、化学療法、ホルモン療法、その他） ・がん治療薬のパーソナライズの世界市場規模：用途別（乳がん、血液がん、消化器がん、前立腺がん、皮膚がん、その他） ・がん治療薬のパーソナライズのアメリカ市場規模（種類別、用途別） ・がん治療薬のパーソナライズのヨーロッパ市場規模（種類別、用途別） ・がん治療薬のパーソナライズの中国市場規模（種類別、用途別） ・がん治療薬のパーソナライズの日本市場規模（種類別、用途別） ・がん治療薬のパーソナライズの東南アジア市場規模（種類別、用途別） ・がん治療薬のパーソナライズのインド市場規模（種類別、用途別） ・がん治療薬のパーソナライズの中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・がん治療薬のパーソナライズの世界市場予測（2019年-2025年） ・がん治療薬のパーソナライズの地域別市場予測（2019年-2025年） ... |
Global cancer drugs market is primarily driven by growing incidences of target disease such as lung cancer, breast cancer, cervical cancer, etc. across the globe. Other major driving factors are increasing research and development on biological and targeted drug therapies for the treatment of cancer coupled along with the expiration of patents.In 2018, the global Personalizing Cancer Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of 6.9% during 2019-2025.
This report focuses on the global Personalizing Cancer Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Personalizing Cancer Drugs development in United States, Europe and China.
The key players covered in this study
Bayer
GlaxoSmithKline
Novartis
Sanofi
Pfizer
Amgen
Merck
Bristol-Myers Squibb
Celgene Corporation
Ariad Pharmaceuticals
Eli Lilly
Hoffmann-La Roche
Boehringer Ingelheim
Johnson and Johnson
Teva Pharmaceuticals
Market segment by Type, the product can be split into
Immunotherapy
Targeted Therapy
Chemotherapy
Hormone Therapy
Others
Market segment by Application, split into
Breast Cancer
Blood Cancer
Gastrointestinal Cancer
Prostate Cancer
Skin Cancer
Lung Cancer
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Personalizing Cancer Drugs status, future forecast, growth opportunity, key market and key players.
To present the Personalizing Cancer Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Personalizing Cancer Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Personalizing Cancer Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Immunotherapy
1.4.3 Targeted Therapy
1.4.4 Chemotherapy
1.4.5 Hormone Therapy
1.4.6 Others
1.5 Market by Application
1.5.1 Global Personalizing Cancer Drugs Market Share by Application (2014-2025)
1.5.2 Breast Cancer
1.5.3 Blood Cancer
1.5.4 Gastrointestinal Cancer
1.5.5 Prostate Cancer
1.5.6 Skin Cancer
1.5.7 Lung Cancer
1.5.8 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Personalizing Cancer Drugs Market Size
2.2 Personalizing Cancer Drugs Growth Trends by Regions
2.2.1 Personalizing Cancer Drugs Market Size by Regions (2014-2025)
2.2.2 Personalizing Cancer Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Personalizing Cancer Drugs Market Size by Manufacturers
3.1.1 Global Personalizing Cancer Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Personalizing Cancer Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Personalizing Cancer Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Personalizing Cancer Drugs Key Players Head office and Area Served
3.3 Key Players Personalizing Cancer Drugs Product/Solution/Service
3.4 Date of Enter into Personalizing Cancer Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Personalizing Cancer Drugs Market Size by Type (2014-2019)
4.2 Global Personalizing Cancer Drugs Market Size by Application (2014-2019)
5 United States
5.1 United States Personalizing Cancer Drugs Market Size (2014-2019)
5.2 Personalizing Cancer Drugs Key Players in United States
5.3 United States Personalizing Cancer Drugs Market Size by Type
5.4 United States Personalizing Cancer Drugs Market Size by Application
6 Europe
6.1 Europe Personalizing Cancer Drugs Market Size (2014-2019)
6.2 Personalizing Cancer Drugs Key Players in Europe
6.3 Europe Personalizing Cancer Drugs Market Size by Type
6.4 Europe Personalizing Cancer Drugs Market Size by Application
7 China
7.1 China Personalizing Cancer Drugs Market Size (2014-2019)
7.2 Personalizing Cancer Drugs Key Players in China
7.3 China Personalizing Cancer Drugs Market Size by Type
7.4 China Personalizing Cancer Drugs Market Size by Application
8 Japan
8.1 Japan Personalizing Cancer Drugs Market Size (2014-2019)
8.2 Personalizing Cancer Drugs Key Players in Japan
8.3 Japan Personalizing Cancer Drugs Market Size by Type
8.4 Japan Personalizing Cancer Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Personalizing Cancer Drugs Market Size (2014-2019)
9.2 Personalizing Cancer Drugs Key Players in Southeast Asia
9.3 Southeast Asia Personalizing Cancer Drugs Market Size by Type
9.4 Southeast Asia Personalizing Cancer Drugs Market Size by Application
10 India
10.1 India Personalizing Cancer Drugs Market Size (2014-2019)
10.2 Personalizing Cancer Drugs Key Players in India
10.3 India Personalizing Cancer Drugs Market Size by Type
10.4 India Personalizing Cancer Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Personalizing Cancer Drugs Market Size (2014-2019)
11.2 Personalizing Cancer Drugs Key Players in Central & South America
11.3 Central & South America Personalizing Cancer Drugs Market Size by Type
11.4 Central & South America Personalizing Cancer Drugs Market Size by Application
12 International Players Profiles
12.1 Bayer
12.1.1 Bayer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Personalizing Cancer Drugs Introduction
12.1.4 Bayer Revenue in Personalizing Cancer Drugs Business (2014-2019)
12.1.5 Bayer Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Company Details
12.2.2 Company Description and Business Overview
12.2.3 Personalizing Cancer Drugs Introduction
12.2.4 GlaxoSmithKline Revenue in Personalizing Cancer Drugs Business (2014-2019)
12.2.5 GlaxoSmithKline Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Personalizing Cancer Drugs Introduction
12.3.4 Novartis Revenue in Personalizing Cancer Drugs Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Sanofi
12.4.1 Sanofi Company Details
12.4.2 Company Description and Business Overview
12.4.3 Personalizing Cancer Drugs Introduction
12.4.4 Sanofi Revenue in Personalizing Cancer Drugs Business (2014-2019)
12.4.5 Sanofi Recent Development
12.5 Pfizer
12.5.1 Pfizer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Personalizing Cancer Drugs Introduction
12.5.4 Pfizer Revenue in Personalizing Cancer Drugs Business (2014-2019)
12.5.5 Pfizer Recent Development
12.6 Amgen
12.6.1 Amgen Company Details
12.6.2 Company Description and Business Overview
12.6.3 Personalizing Cancer Drugs Introduction
12.6.4 Amgen Revenue in Personalizing Cancer Drugs Business (2014-2019)
12.6.5 Amgen Recent Development
12.7 Merck
12.7.1 Merck Company Details
12.7.2 Company Description and Business Overview
12.7.3 Personalizing Cancer Drugs Introduction
12.7.4 Merck Revenue in Personalizing Cancer Drugs Business (2014-2019)
12.7.5 Merck Recent Development
12.8 Bristol-Myers Squibb
12.8.1 Bristol-Myers Squibb Company Details
12.8.2 Company Description and Business Overview
12.8.3 Personalizing Cancer Drugs Introduction
12.8.4 Bristol-Myers Squibb Revenue in Personalizing Cancer Drugs Business (2014-2019)
12.8.5 Bristol-Myers Squibb Recent Development
12.9 Celgene Corporation
12.9.1 Celgene Corporation Company Details
12.9.2 Company Description and Business Overview
12.9.3 Personalizing Cancer Drugs Introduction
12.9.4 Celgene Corporation Revenue in Personalizing Cancer Drugs Business (2014-2019)
12.9.5 Celgene Corporation Recent Development
12.10 Ariad Pharmaceuticals
12.10.1 Ariad Pharmaceuticals Company Details
12.10.2 Company Description and Business Overview
12.10.3 Personalizing Cancer Drugs Introduction
12.10.4 Ariad Pharmaceuticals Revenue in Personalizing Cancer Drugs Business (2014-2019)
12.10.5 Ariad Pharmaceuticals Recent Development
12.11 Eli Lilly
12.12 Hoffmann-La Roche
12.13 Boehringer Ingelheim
12.14 Johnson and Johnson
12.15 Teva Pharmaceuticals
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Personalizing Cancer Drugs Key Market Segments
Table Key Players Personalizing Cancer Drugs Covered
Table Global Personalizing Cancer Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Personalizing Cancer Drugs Market Size Market Share by Type 2014-2025
Figure Immunotherapy Figures
Table Key Players of Immunotherapy
Figure Targeted Therapy Figures
Table Key Players of Targeted Therapy
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Hormone Therapy Figures
Table Key Players of Hormone Therapy
Figure Others Figures
Table Key Players of Others
Table Global Personalizing Cancer Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Breast Cancer Case Studies
Figure Blood Cancer Case Studies
Figure Gastrointestinal Cancer Case Studies
Figure Prostate Cancer Case Studies
Figure Skin Cancer Case Studies
Figure Lung Cancer Case Studies
Figure Others Case Studies
Figure Personalizing Cancer Drugs Report Years Considered
Table Global Personalizing Cancer Drugs Market Size 2014-2025 (Million US$)
Figure Global Personalizing Cancer Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Personalizing Cancer Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Personalizing Cancer Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Personalizing Cancer Drugs Market Share by Regions 2014-2019
Figure Global Personalizing Cancer Drugs Market Share by Regions 2014-2019
Figure Global Personalizing Cancer Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Personalizing Cancer Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Personalizing Cancer Drugs Market Share by Manufacturers (2014-2019)
Figure Global Personalizing Cancer Drugs Market Share by Manufacturers in 2018
Table Global Personalizing Cancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Personalizing Cancer Drugs Product/Solution/Service
Table Date of Enter into Personalizing Cancer Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Personalizing Cancer Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Personalizing Cancer Drugs Market Size Share by Type (2014-2019)
Figure Global Personalizing Cancer Drugs Market Size Market Share by Type (2014-2019)
Table Global Personalizing Cancer Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Personalizing Cancer Drugs Market Size Share by Application (2014-2019)
Figure Global Personalizing Cancer Drugs Market Size Market Share by Application (2014-2019)
Figure Global Personalizing Cancer Drugs Revenue Market Share by Application in 2018
Figure United States Personalizing Cancer Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Personalizing Cancer Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Personalizing Cancer Drugs Market Share (2018-2019)
Table United States Personalizing Cancer Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Personalizing Cancer Drugs Market Share by Type (2014-2019)
Table United States Personalizing Cancer Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Personalizing Cancer Drugs Market Share by Application (2014-2019)
Figure Europe Personalizing Cancer Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Personalizing Cancer Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Personalizing Cancer Drugs Market Share (2018-2019)
Table Europe Personalizing Cancer Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Personalizing Cancer Drugs Market Share by Type (2014-2019)
Table Europe Personalizing Cancer Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Personalizing Cancer Drugs Market Share by Application (2014-2019)
Figure China Personalizing Cancer Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Personalizing Cancer Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Personalizing Cancer Drugs Market Share (2018-2019)
Table China Personalizing Cancer Drugs Market Size by Type (2014-20189) (Million US$)
Table China Personalizing Cancer Drugs Market Share by Type (2014-2019)
Table China Personalizing Cancer Drugs Market Size by Application (2014-2019) (Million US$)
Table China Personalizing Cancer Drugs Market Share by Application (2014-2019)
Figure Japan Personalizing Cancer Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Personalizing Cancer Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Personalizing Cancer Drugs Market Share (2018-2019)
Table Japan Personalizing Cancer Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Personalizing Cancer Drugs Market Share by Type (2014-2019)
Table Japan Personalizing Cancer Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Personalizing Cancer Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Personalizing Cancer Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Personalizing Cancer Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Personalizing Cancer Drugs Market Share (2018-2019)
Table Southeast Asia Personalizing Cancer Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Personalizing Cancer Drugs Market Share by Type (2014-2019)
Table Southeast Asia Personalizing Cancer Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Personalizing Cancer Drugs Market Share by Application (2014-2019)
Figure India Personalizing Cancer Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Personalizing Cancer Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Personalizing Cancer Drugs Market Share (2018-2019)
Table India Personalizing Cancer Drugs Market Size by Type (2014-2019) (Million US$)
Table India Personalizing Cancer Drugs Market Share by Type (2014-2019)
Table India Personalizing Cancer Drugs Market Size by Application (2014-2019) (Million US$)
Table India Personalizing Cancer Drugs Market Share by Application (2014-2019)
Figure Central & South America Personalizing Cancer Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Personalizing Cancer Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Personalizing Cancer Drugs Market Share (2018-2019)
Table Central & South America Personalizing Cancer Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Personalizing Cancer Drugs Market Share by Type (2014-2019)
Table Central & South America Personalizing Cancer Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Personalizing Cancer Drugs Market Share by Application (2014-2019)
Table Bayer Company Details
Table Bayer Revenue in Personalizing Cancer Drugs Business (2014-2019) (Million US$)
Figure Bayer Revenue Growth Rate in Personalizing Cancer Drugs Business (2014-2019)
Table Bayer Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Personalizing Cancer Drugs Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Personalizing Cancer Drugs Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Novartis Company Details
Table Novartis Revenue in Personalizing Cancer Drugs Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Personalizing Cancer Drugs Business (2014-2019)
Table Novartis Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Personalizing Cancer Drugs Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Personalizing Cancer Drugs Business (2014-2019)
Table Sanofi Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Personalizing Cancer Drugs Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Personalizing Cancer Drugs Business (2014-2019)
Table Pfizer Recent Development
Table Amgen Company Details
Table Amgen Revenue in Personalizing Cancer Drugs Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Personalizing Cancer Drugs Business (2014-2019)
Table Amgen Recent Development
Table Merck Company Details
Table Merck Revenue in Personalizing Cancer Drugs Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Personalizing Cancer Drugs Business (2014-2019)
Table Merck Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Personalizing Cancer Drugs Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Personalizing Cancer Drugs Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Celgene Corporation Company Details
Table Celgene Corporation Revenue in Personalizing Cancer Drugs Business (2014-2019)(Million US$)
Figure Celgene Corporation Revenue Growth Rate in Personalizing Cancer Drugs Business (2014-2019)
Table Celgene Corporation Recent Development
Table Ariad Pharmaceuticals Company Details
Table Ariad Pharmaceuticals Revenue in Personalizing Cancer Drugs Business (2014-2019)(Million US$)
Figure Ariad Pharmaceuticals Revenue Growth Rate in Personalizing Cancer Drugs Business (2014-2019)
Table Ariad Pharmaceuticals Recent Development
Table Eli Lilly Company Details
Table Hoffmann-La Roche Company Details
Table Boehringer Ingelheim Company Details
Table Johnson and Johnson Company Details
Table Teva Pharmaceuticals Company Details
Table Global Personalizing Cancer Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Personalizing Cancer Drugs Market Size Share by Regions (2019-2025)
Figure Global Personalizing Cancer Drugs Market Size Share by Regions in 2025
Figure United States Personalizing Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Personalizing Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Personalizing Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Personalizing Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Personalizing Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Personalizing Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Personalizing Cancer Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Personalizing Cancer Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Personalizing Cancer Drugs Market Size by Product (2019-2025)
Figure Global Personalizing Cancer Drugs Market Size by Product in 2025
Table Global Personalizing Cancer Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Personalizing Cancer Drugs Market Size by Application (2019-2025)
Figure Global Personalizing Cancer Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の転移性乳がんの治療市場：市場規模・現状・予測 Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…- 世界の婦人科がん治療薬市場2019 The global Gynecological Cancer Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report studies the global Gynecological Cancer Drugs market status and forecast, categorizes the global Gynecological Ca…
- 世界の前立腺がんバイオマーカー市場：市場規模・現状・予測 Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system.The prostate cancer biomarker market is expected to witness a fast growth owing to rising prevalence of prostate cancer. In 2018, the global Prostate Cancer Biomarker market size was xx million US$ …
- 世界の精密がん治療市場：市場規模・現状・予測 Precision cancer therapies is an evolving approach to cancer care that aims to leverage new knowledge regarding the pathogenesis of cancer to more precisely target therapy.Precision cancer medicine utilizes molecular diagnostic testing, including DNA sequencing, to identify cancer-driving abnormalit…
- 世界の男性の乳がんの治療市場：市場規模・現状・予測 Male breast cancer (male breast neoplasm) is a rare cancer in males that originates from the breast. Many males with breast cancer have inherited a BRCA mutation, but there are other causes, including alcohol abuse and exposure to certain hormones and ionizing radiation.In 2018, the global Male Brea…